ACXP vs RCL · $11.3M cap vs P/E 26, rev $9.28B
Acurx Pharmaceuticals LLC (ACXP) versus Royal Caribbean Cruises Ltd (RCL) — a side-by-side from cached financials, not a winner call.
Acurx Pharmaceuticals LLC (ACXP) is a biotechnology company listed on US.
Royal Caribbean Cruises Ltd (RCL) is a travel services company listed on US.
ACXP does not have a complete income-statement cache yet.
Latest reported RCL revenue for 2026-06-30 was $9.28B. Net income was $2.07B. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
ACXP currently screens at market cap $11.3M. RCL currently screens at market cap $85.57B and trailing P/E 25.7.
Not investment advice. Open the ACXP and RCL stock pages for the full models.
Not investment advice.